Jeffrey Karp, Ph.D., Co-Director, Center for Regenerative Therapeutics; Associate Bioengineer, Brigham and Women’s Hospital; and Assistant Professor, Harvard Medical School

Previous articleStudies Show Natural Protein May Provide Benefits Against Stroke up to 12 Hours After Onset
Next articleAxxam and Polyphor Receive €3.1M for GLP-1 Receptor Diabetes Program